Literature DB >> 2605805

Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study.

F B De Waard-van der Spek, A P Oranje, D M De Raeymaecker, J D Peereboom-Wynia.   

Abstract

We report a retrospective study of 209 patients presenting with alopecia areata (AA) at our skin department during the period 1969-1987, with special reference to possible associations, aetiological factors and the relevance of additional investigations. The patients were divided into two groups: (I) those in whom AA developed during childhood; (II) those in whom AA developed in adult life (greater than or equal to 16 years). The aim of this study was to establish whether there is a difference between juvenile and maturity-onset AA and to consider the value of additional investigations in AA. Juvenile AA is more severe and has a less favourable prognosis than the maturity-onset disease. Statistically significant differences between the two groups were not found with respect to AA type and prevalence of auto-antibodies. Bad prognostic signs in AA were early age of onset, atopy (or first-degree family history) and ophiasis and/or onychodystrophy. Initial thyroid function testing seems advisable in patients with AA. Additional valuable investigations may include hair-root examination, determination of antibodies against thyroid tissue, and serum zinc levels. There are indications that psychosomatic factors may play a role in AA. In our study, psychosomatic factors were found in 29% of the juvenile AA and in 17% of the maturity-onset AA patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605805     DOI: 10.1111/j.1365-2230.1989.tb02604.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  17 in total

Review 1.  Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.

Authors:  Ralph M Trüeb; Maria Fernanda Reis Gavazzoni Dias
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Medium-dose prednisolone pulse therapy in alopecia areata.

Authors:  Pinelopi Efentaki; Andreas Altenburg; Johannes Haerting; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-11

Review 3.  Alopecia areata: Part 1: pathogenesis, diagnosis, and prognosis.

Authors:  Frank Spano; Jeff C Donovan
Journal:  Can Fam Physician       Date:  2015-09       Impact factor: 3.275

Review 4.  Alopecia Areata: An Update on Treatment Options for Children.

Authors:  Lauren Peloquin; Leslie Castelo-Soccio
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

5.  Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis.

Authors:  Solam Lee; Beom Jun Kim; Chung-Hyeok Lee; Won-Soo Lee
Journal:  JAMA Dermatol       Date:  2019-05-01       Impact factor: 10.282

Review 6.  Alopecia areata.

Authors:  C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg
Journal:  Nat Rev Dis Primers       Date:  2017-03-16       Impact factor: 52.329

7.  The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review.

Authors:  Calvin T Sung; Franchesca D Choi; Margit Juhász; Natasha Atanaskova Mesinkovska
Journal:  Skin Appendage Disord       Date:  2019-02-26

8.  Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis.

Authors:  Hyun Hee Cho; Seong Jin Jo; Seung Hwan Paik; Hye Chan Jeon; Kyu Han Kim; Hee Chul Eun; Oh Sang Kwon
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

9.  Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients.

Authors:  Hassan Seyrafi; Maryam Akhiani; Hamed Abbasi; Sahar Mirpour; Ali Gholamrezanezhad
Journal:  BMC Dermatol       Date:  2005-10-31

10.  Current treatment strategies in pediatric alopecia areata.

Authors:  Etienne Wang; Joyce Ss Lee; Mark Tang
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.